# The Effects of Stromal Vascular Fraction and Mesenchymal Stem Cells as Intra-articular Injection in Knee Joint Osteoarthritis

> **NCT03164083** · PHASE2 · WITHDRAWN · sponsor: **SCARM Institute, Tabriz, Iran**

## Conditions studied

- Osteoarthritis

## Interventions

- **BIOLOGICAL:** Mesenchymal stem cell
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT03164083
- **Lead sponsor:** SCARM Institute, Tabriz, Iran
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-11-10
- **Primary completion:** 2020-08-21
- **Final completion:** 2020-12-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** not approved by sponsor
- **Last updated:** 2020-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03164083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03164083, "The Effects of Stromal Vascular Fraction and Mesenchymal Stem Cells as Intra-articular Injection in Knee Joint Osteoarthritis". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03164083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*